MED1 chromatin binding at the BRCA1 mutation-affected super-enhancers showed a trend of decrease, albeit statistically insignificant, in BRCA1 185delAG/+ MCF10A clones versus the WT control (Fig. 4 c).
← all excerpts
BRCA1 mutations attenuate super-enhancer function and chromatin looping in haploinsufficient human breast epithelial cells.
1
—
—